Adir Et Compagnie

Laboratories Negma

Isabelle Lesieur

Pierre Renard

Patrick Depreux

Beatrice Guardiola

Daniel H Caignard

Gerard Adam

Said Yous

Thierry Taverne

Michelle Devissaguet

Daniel Lesieur

Daniel-Henri Caignard

Philippe Delagrange

Marie-Claire Rettori

Charles Lespagnol

Hamid Ait Mansour

Veronique Leclerc

Yannis Tsouderos

Raymond Houssin

Geard Adam

Beatrice Guardiola Lemaitre

Jean-Claude Fruchart

Nicole Monfilliette

Jacques Sauzieres

Ziaddine Moussavi

The invention relates to a compound selected from those of formula (I): ##STR1## in which A, B, X and R.sub.1 are as defined in the description, and medicinal product containing the same useful for treating a disorder of the melatoninergic system.

Arylalkyl(thio)carboxamides

The invention relates to the compounds of formula (I): ##STR1## in which R.sub.1 and R.sup.2 are as defined in the description, the optical isomers thereof, and an addition salt thereof with a pharmaceutically-acceptable acid or base, and medicinal product useful for treating a mammal afflicted with a disease associated with sigma receptors.

Aminoalkyl benzothiazolinones

Compounds of general formula (I): ##STR1## where R, X, A, B and p are defined in the description. Medicinal products useful for treating sleep disorders comprising the same.

Benzoxazolinonyl substituted alkylamines

Compounds of general formula (I): ##STR1## where R, X, A, B and p are defined in the description. Medicinal products. Useful for treating sleep disorders comprising the same.

2-(alkoxy benzothiazolinon-3yl) ethylamines

Benzoxazolinonyl alkylamides

Benzoxazalinonyl and benzothiazolinonyl ethyl isonicotine amides and

Compounds of general formula (I): ##STR1## wherein R, X, A, B and p are defined in the description. Medicinal products useful for treating sleep disorders comprising the same.

Benzoxazolinonyl and benzothiazolinonyl ethyl morpholinoacetamides

Compounds of general formula (I): ##STR1## where R, X, A, B and p are defined in the description. Medicinal products useful for treating sleeping disorders comprising the same.

New heterocycle-substituted alkylamides

Compounds of general formula (I): ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, n, X and A are defined in the description. Medicinal products containing the same are useful as antidepressives or anxiolytics due to their 5-HT1A receptor agonist activity.

Aminoalkyl benzoxazine and benzthiazine compounds having a high

Aminoalkyl-benzothiazolinone and -benzoxazolinone compounds having a

Benzthiazolinonyl-substituted alkylamides

Compound of general formula (I): ##STR1## where R.sub.1, R.sub.2, R.sub.3, n and X are defined in the description. Medicinal products.

Benzothiazine and benzothiazole compounds useful as analgesics

Benzoxazinone compounds of general formula (I): ##STR1## useful in the treatment of serotoninergic disorders, especially anxiety and schizophrenia, requiring for their treatment compounds which are 5-HT.sub.1A receptor agonists, wherein R.sub.1, R.sub.2, R.sub.3, and n are as defined in the description, and medicinal products containing the same, are disclosed.

Benzoxazinone compounds

Compound of general formula (I): ##STR1## where R.sub.1, R.sub.2, R.sub.3, n, X and A are defined in the description. Medicinal products.

Heterocycle-substituted alkylamines compounds

Compounds of general formula (I): in which: ##STR1## R.sub.1, X, Y, Z, T, R.sub.2, R.sub.3 and R.sub.4 are defined in the description. Medicinal products.

Growing community of inventors

Gondecourt, France

Isabelle Lesieur